Cargando…

KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis

BACKGROUND: Uveitis is a potentially sight-threatening form of ocular inflammation that affects the uvea in the wall of the eye. Currently available treatments for uveitis have exhibited profound adverse side effects. However, KS23 is a novel 23-amino-acid anti-inflammatory peptide derived from adip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Tian, Cheng, Lu, Wang, Hanying, Zhu, Shaopin, Yang, Xiaolu, Liu, Kun, Jin, Huiyi, Xu, Xun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935244/ https://www.ncbi.nlm.nih.gov/pubmed/31883532 http://dx.doi.org/10.1186/s12974-019-1686-y

Ejemplares similares

The Anti-Inflammatory Effect of KS23, A Novel Peptide Derived From Globular Adiponectin, on Endotoxin-Induced Uveitis in Rats
por: Shi, Xin, et al.
Publicado: (2021)

Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells
por: Bing, So Jin, et al.
Publicado: (2020)

Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis
por: Guo, Kailei, et al.
Publicado: (2021)

Bidirectional Effect of IFN-γ on Th17 Responses in Experimental Autoimmune Uveitis
por: Shao, Hui, et al.
Publicado: (2022)

Sleep loss potentiates Th17‐cell pathogenicity and promotes autoimmune uveitis
por: Liu, Xiuxing, et al.
Publicado: (2023)

Overexpressing Kallistatin Aggravates Experimental Autoimmune Uveitis Through Promoting Th17 Differentiation
por: Chen, Nu, et al.
Publicado: (2021)

Aging weakens Th17 cell pathogenicity and ameliorates experimental autoimmune uveitis in mice
por: Li, He, et al.
Publicado: (2021)

The Role of Adenosine in γδ T-Cell Regulation of Th17 Responses in Experimental Autoimmune Uveitis
por: Shao, Hui, et al.
Publicado: (2023)

Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses
por: Wu, Sihan, et al.
Publicado: (2021)

Progranulin Suppressed Autoimmune Uveitis and Autoimmune Neuroinflammation by Inhibiting Th1/Th17 Cells and Promoting Treg Cells and M2 Macrophages
por: Wang, Chaokui, et al.
Publicado: (2022)

Dietary Omega-3 Fatty Acids Suppress Experimental Autoimmune Uveitis in Association with Inhibition of Th1 and Th17 Cell Function
por: Shoda, Hiromi, et al.
Publicado: (2015)

Adenosine receptor ligation tips the uveitogenic Th1 and Th17 balance towards the latter in experimental autoimmune uveitis-induced mouse
por: Sun, Deming, et al.
Publicado: (2021)

CD73(+) Dendritic Cells in Cascading Th17 Responses of Experimental Autoimmune Uveitis-Induced Mice
por: Ko, MinHee K., et al.
Publicado: (2020)

Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis
por: Jia, Xiuzhi, et al.
Publicado: (2011)

Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2/Pim1 axis
por: Liu, Xiuxing, et al.
Publicado: (2023)

Th17 Cells in Immunity and Autoimmunity
por: Bedoya, Simone Kennedy, et al.
Publicado: (2013)

Role of Th17 cells and IL-17, IL-23 cytokines in pathogenesis of autoimmune thyroid disease in children
por: Bossowski, Artur, et al.
Publicado: (2013)

Therapeutic Effect of IL-38 on Experimental Autoimmune Uveitis: Reprogrammed Immune Cell Landscape and Reduced Th17 Cell Pathogenicity
por: Li, He, et al.
Publicado: (2021)

TLR ligand ligation switches adenosine receptor usage of BMDCs leading to augmented Th17 responses in experimental autoimmune uveitis
por: Sun, Deming, et al.
Publicado: (2022)

An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) via Dendritic Cell Activation
por: Chen, Mingjiazi, et al.
Publicado: (2015)

MicroRNAs in the regulation of Th17/Treg homeostasis and their potential role in uveitis
por: Tang, Fen, et al.
Publicado: (2022)

Th17 Response and Inflammatory Autoimmune Diseases
por: Waite, Janelle C., et al.
Publicado: (2012)

Th17 Cells in Autoimmune and Infectious Diseases
por: Zambrano-Zaragoza, José Francisco, et al.
Publicado: (2014)

The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases
por: Tabarkiewicz, Jacek, et al.
Publicado: (2015)

IL-23 and Th17 Disease in Inflammatory Arthritis
por: Yago, Toru, et al.
Publicado: (2017)

T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis
por: Napier, Ruth J., et al.
Publicado: (2020)

Total glucosides of paeony suppresses experimental autoimmune uveitis in association with inhibition of Th1 and Th2 cell function in mice
por: Huang, Xue-Tao, et al.
Publicado: (2018)

TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?
por: Marwaha, Ashish K., et al.
Publicado: (2012)

The Balance of Th17 versus Treg Cells in Autoimmunity
por: Lee, Gap Ryol
Publicado: (2018)

Enhanced Th17 Responses in Patients with Autoimmune Hepatitis
por: Behfarjam, Farinaz, et al.
Publicado: (2019)

Downregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasis
por: FU, DANDAN, et al.
Publicado: (2016)

Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
por: Domingues, Helena S., et al.
Publicado: (2010)

T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease
por: O'Connor, Richard A, et al.
Publicado: (2013)

PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease
por: Qu, Zhaoxia, et al.
Publicado: (2012)

Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments
por: Li, Shujuan, et al.
Publicado: (2014)

Calcitriol inhibits osteoclastogenesis in an inflammatory environment by changing the proportion and function of T helper cell subsets (Th2/Th17)
por: Bi, Chun‐Sheng, et al.
Publicado: (2020)

Increased Proportion of Dual-Positive Th2–Th17 Cells Promotes a More Severe Subtype of Asthma
por: Sun, Wenjin, et al.
Publicado: (2021)

Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitis
por: Chen, Yi Hsing, et al.
Publicado: (2021)

Neutralization of interleukin-17 suppresses allergic rhinitis symptoms by downregulating Th2 and Th17 responses and upregulating the Treg response
por: Gu, Zhao Wei, et al.
Publicado: (2017)

Interleukin-23 and Th17 Cells in the Control of Gut Inflammation
por: Monteleone, Ivan, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0vppj4j2r51ai71t1ge00d6ruk